Company profilePharmaceutical#507 of 1,318 in Pakistan✓ No DRAP alerts

S. EJAZUDDIN & COMPANY

Pharmaceutical company · 26 brands · 29 molecules

Ranked #19 of 44 companies in Antineoplastics

26 registered products 16 pharmaceutical brands 29 distinct molecules 0 DRAP alerts

Company overview

26
registered products
16
pharmaceutical brands
29
distinct molecules
3
therapeutic classes
0
DRAP alerts

S. EJAZUDDIN & COMPANY is a pharmaceutical manufacturer registered with the Drug Regulatory Authority of Pakistan, holding 26 product registrations across 29 distinct molecules. Its portfolio is concentrated in Antineoplastics and Immunostimulants. It has no DRAP recall, shortage or safety notices on record.

Compiled from the DRAP registry, DRAP approved prices and DRAP alerts, with observed retail from DVAGO and Servaid. Data as of 2026-07-30.

Top molecules by brand count

Filgrastim2 brands
Mitomycin C2 brands
Fosfomycin2 brands
Barium2 brands
Cephalexin1 brand
Mitomycin1 brand
Etoposide1 brand
Timolol1 brand

Therapeutic classes

Antineoplastics · 4Immunostimulants · 2Blood Substitutes And Plasma Protein Fractions (Hospital Solution) · 1

Price band (DRAP official ceilings)

Registered products priced by source
DRAP-official3 products · Rs 75.66 – Rs 618.12
Median across source: Rs 201.93

Regulatory record

No DRAP alerts on record

No recalls, shortage notices or safety alerts involving this company’s products appear in the DRAP alert feed we track. Median across all 1,318 mapped companies is zero — 1,165 of them also have a clean sheet.

Competitive set

Companies whose registered portfolio overlaps most with this one.

Get the full profile for S.

This page is a summary. The full company brief adds every registration with its approved ceiling and approval date, per-molecule competitive position, price positioning against the category, and a launch shortlist built from the whitespace above.

Request this brief See what’s included

Company data as of 2026-07-30. Brand and molecule counts from the DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.